Skip to main content
Erschienen in: Journal of Endocrinological Investigation 10/2017

01.10.2017 | Original Article

Quality of life after thyroid surgery

verfasst von: S. Dogan, N. A. Sahbaz, N. Aksakal, F. Tutal, B. C. Torun, N. K. Yıldırım, M. Özkan, B. Ozcinar, Y. Erbil

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to inquire how patients’ quality of life is affected after thyroid surgery and the factors involved.

Methods

A semi-structured questionnaire and the World Health Organization Quality of Life Scale (WHOQOL-BREF) were applied to 101 patients prior to surgery. Thereafter data was collected in the early and again in the late post-operative period.

Results

Mean general health score for pre-operative quality of life was 6.72 ± 1.53 (3–10), mean physical field score was 22.81 ± 2.77 (17–31), mean psychological field score was 21.69 ± 2.78 (15–28), mean social field score was 11.10 ± 1.94 (5–15) and mean environmental field score was 27.86 ± 4.30 (18–39). In the early post-operative period, mean general health score was 7.05 ± 1.45 (4–10), mean physical field score was 22.84 ± 2.83 (14–29), mean psychological field score was 21.67 ± 2.32 (16–27), mean social field score was 10.89 ± 1.96 (5–15) and mean environmental field score was 28.56 ± 4.18 (18–40). In the late post-operative period, the general health score for quality of life was 7.43 ± 1.34 (4–10), mean physical field score was 23.59 ± 2.70 (17–35), mean psychological field score was 21.75 ± 2.34 (14–29), mean social field score was 11.23 ± 1.94 (6–15) and mean on-field environment score was 29.30 ± 3.96 (16–40). The pre-operative levels of symptoms were found to be higher than early and late post-operative periods.

Conclusions

Quality of life increased after total thyroidectomy and statistically significant improvement was observed in late post-operative stage.
Literatur
1.
Zurück zum Zitat Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F et al (1977) The spectrum of thyroid disease in a community: the Whickham survery. Clin Endocrinol (Oxf) 7:481–493CrossRef Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F et al (1977) The spectrum of thyroid disease in a community: the Whickham survery. Clin Endocrinol (Oxf) 7:481–493CrossRef
2.
Zurück zum Zitat Vander JB, Gaston EA, Dawber TR (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the insidence of thyroid malignancy. Ann Intern Med 69:537–540CrossRefPubMed Vander JB, Gaston EA, Dawber TR (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the insidence of thyroid malignancy. Ann Intern Med 69:537–540CrossRefPubMed
3.
Zurück zum Zitat Mortensen JD, Woolner LB, Bennet WA (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280CrossRefPubMed Mortensen JD, Woolner LB, Bennet WA (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280CrossRefPubMed
4.
Zurück zum Zitat Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840CrossRefPubMed Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840CrossRefPubMed
5.
Zurück zum Zitat Iyer NG, Shaha AR (2010) Management of thyroid nodules and surgery for differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 22:405–412CrossRef Iyer NG, Shaha AR (2010) Management of thyroid nodules and surgery for differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 22:405–412CrossRef
6.
Zurück zum Zitat Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S.,1985–1995 (see commetns). Cancer 83:2638–2648CrossRefPubMed Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S.,1985–1995 (see commetns). Cancer 83:2638–2648CrossRefPubMed
7.
Zurück zum Zitat Randolph GW, Thompson GB, Branovan DI, Tuttle RM (2007) Treatment of thyroid cancer: 2007—a basic review. Int J Radiat Oncol Biol Phys 69:S92–S97CrossRefPubMed Randolph GW, Thompson GB, Branovan DI, Tuttle RM (2007) Treatment of thyroid cancer: 2007—a basic review. Int J Radiat Oncol Biol Phys 69:S92–S97CrossRefPubMed
8.
Zurück zum Zitat Fidaner H, Elbi H, Fidaner C, Eser SY (1999) Yaşam Kalitesinin Ölçülmesi, WHOQOL-100 ve WHOQOL-BRIEF. 3P Dergisi 7: 5–13 Fidaner H, Elbi H, Fidaner C, Eser SY (1999) Yaşam Kalitesinin Ölçülmesi, WHOQOL-100 ve WHOQOL-BRIEF. 3P Dergisi 7: 5–13
9.
Zurück zum Zitat Dow KH, Ferrell BR, Anello C (1997) Balancing demands of cancer surveillance among survivors of thyroid cancer. CancerPractice 5:289–295 Dow KH, Ferrell BR, Anello C (1997) Balancing demands of cancer surveillance among survivors of thyroid cancer. CancerPractice 5:289–295
10.
Zurück zum Zitat Tagay S, Herpertz S, Langkafel M, Erim Y, Bockisch A, Senf W et al (2006) Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 15:695–703CrossRefPubMed Tagay S, Herpertz S, Langkafel M, Erim Y, Bockisch A, Senf W et al (2006) Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 15:695–703CrossRefPubMed
11.
Zurück zum Zitat Tan LG, Non L, Thumboo J, Sundram F, Tan LK (2007) Health-related quality of life in thyroid cancer survivors. Laryngoscope 117:507–510CrossRefPubMed Tan LG, Non L, Thumboo J, Sundram F, Tan LK (2007) Health-related quality of life in thyroid cancer survivors. Laryngoscope 117:507–510CrossRefPubMed
12.
Zurück zum Zitat Mishra A, Sabaretnam M, Chand G, Agarwal G, Agarwal A, Verma AK et al (2013) Quality of life in patients with benign thyroid goiters (pre-and post-thyroidectomy): a prospective study. World J Surg 37:2322–2329CrossRefPubMed Mishra A, Sabaretnam M, Chand G, Agarwal G, Agarwal A, Verma AK et al (2013) Quality of life in patients with benign thyroid goiters (pre-and post-thyroidectomy): a prospective study. World J Surg 37:2322–2329CrossRefPubMed
13.
Zurück zum Zitat Rubic M, Kuna SK, Tesic V, Samardzic T, Despot M, Huic D (2014) The most common factors influencing on quality of life of thyroid cancer patients after thyroid hormone withdrawal. Psychatr Danub 3:520–527 Rubic M, Kuna SK, Tesic V, Samardzic T, Despot M, Huic D (2014) The most common factors influencing on quality of life of thyroid cancer patients after thyroid hormone withdrawal. Psychatr Danub 3:520–527
14.
Zurück zum Zitat Botella-Carretero JI, Gala´n JM, Caballero C, Sanco J, Escobar-Morreale HF (2003) Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 10:601–610CrossRefPubMed Botella-Carretero JI, Gala´n JM, Caballero C, Sanco J, Escobar-Morreale HF (2003) Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 10:601–610CrossRefPubMed
15.
Zurück zum Zitat Promberger R, Hermann M, Pallikunnel SJ, Seemann R, Meusel M, Ott J (2014) Quality of life after thyroid surgery in women with benign euthyroid goiter: influencing factors including Hashimoto’s thyroiditis. Am J Surg 207:974–979CrossRefPubMed Promberger R, Hermann M, Pallikunnel SJ, Seemann R, Meusel M, Ott J (2014) Quality of life after thyroid surgery in women with benign euthyroid goiter: influencing factors including Hashimoto’s thyroiditis. Am J Surg 207:974–979CrossRefPubMed
Metadaten
Titel
Quality of life after thyroid surgery
verfasst von
S. Dogan
N. A. Sahbaz
N. Aksakal
F. Tutal
B. C. Torun
N. K. Yıldırım
M. Özkan
B. Ozcinar
Y. Erbil
Publikationsdatum
01.10.2017
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 10/2017
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-017-0635-9

Weitere Artikel der Ausgabe 10/2017

Journal of Endocrinological Investigation 10/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.